Senior insider sale
Chief Financial Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$1.25M
46.40K shares
What this filing means
HYEP IVAN plans to sell 46.40K shares of BICARA THERAPEUTICS INC. valued at approximately $1.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/8/2026ACC: 0001969223-26-000771
Officer· Chief Financial Officer
Since Mar 2026
46.40K
Shares to sell
$1.25M
Approx. market value
28K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of stock options
Cash
7/8/2026
12.50KNQ Exercise
NA
5/8/2024
15.50KTotal acquired28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Exercise of stock options Cash | 12.50K | — |
5/8/2024 | NQ Exercise NA | 15.50K | — |
| Total | 28K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
9.20K
Market value
$187.9K
5/21/2026
—Completed
Units to sell
9.20K
Market value
$211.6K
4/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
28K
Market value
$847.0K
7/8/2026
Total
Units
46.40K
Value
$1.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/21/2026 | 9.20K | $187.9K | — | Completed |
4/21/2026 | 9.20K | $211.6K | — | Completed |
| Planned — Approximate Date | ||||
7/8/2026 | 28K | $847.0K | NASDAQ | Planned |
| Total | 46.40K | $1.25M | ||